Anthelmintic; Antiphlogistic; Antiseptic; Astringent; Cholagogue; Depurative; Haemostatic
Bangladesh; South Africa; Nepal; India; China; Thailand; Japan; Taiwan
Ingredient ID: NPC92233
Ingredient ID: NPC85995
Ingredient ID: NPC69101
Ingredient ID: NPC478922
Ingredient ID: NPC478921
Ingredient ID: NPC478920
Ingredient ID: NPC478919
Ingredient ID: NPC478918
Ingredient ID: NPC478917
Ingredient ID: NPC478916
Ingredient ID: NPC478915
Ingredient ID: NPC478914
Ingredient ID: NPC478913
Ingredient ID: NPC43696
Ingredient ID: NPC37919
Ingredient ID: NPC37080
Ingredient ID: NPC321053
Ingredient ID: NPC320242
Ingredient ID: NPC311219
Ingredient ID: NPC305766
Ingredient ID: NPC264145
Ingredient ID: NPC253662
Ingredient ID: NPC225710
Ingredient ID: NPC202154
Ingredient ID: NPC192744
Ingredient ID: NPC173555
Ingredient ID: NPC170138
Ingredient ID: NPC134975
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Enzyme | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Therapeutic Target | Hydrolase | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Therapeutic Target | Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Therapeutic Target | Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Therapeutic Target | Metallo protease | ACE | Angiotensin-converting enzyme | P12821 | CHEMBL1808 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | THRB | Thyroid hormone receptor beta-1 | P10828 | CHEMBL1947 |
Therapeutic Target | P-type ATPase | ATP1A1 | Sodium/potassium-transporting ATPase alpha-1 chain | P05023 | CHEMBL1807 |
Therapeutic Target | Peptide receptor (family A GPCR) | AGTR1 | Type-1 angiotensin II receptor | P30556 | CHEMBL227 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRB1 | Beta-1 adrenergic receptor | P08588 | CHEMBL213 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Therapeutic Target | Transcription factor | PAX8 | Paired box protein Pax-8 | Q06710 | CHEMBL2362980 |
Therapeutic Target | Transferase | POLA1 | DNA polymerase alpha subunit | P09884 | CHEMBL1828 |
Therapeutic Target | Transferase | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Q11130 | CHEMBL3596077 |
Therapeutic Target | Transporter | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 654 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00313157 | RATe Control in Atrial Fibrillation | atrial fibrillation | Metoprolol (NPC320242) | NP level |
NCT00523744 | Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00401882 | Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial | sudden cardiac arrest;ventricular fibrillation;ventricular tachycardia | Metoprolol (NPC320242) | NP level |
NCT03316534 | Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients | HIV infection | Aspirin (NPC311219) | NP level |
NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT05105919 | Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT01523054 | Metoprolol in Acute Myocardial Infarction. A PK/PD Study | acute myocardial infarction | Metoprolol (NPC320242) | NP level |
NCT03957902 | Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT04792723 | Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT00240448 | A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01302691 | MK-0954E Study in Participants With Hypertension (MK-0954E-357) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00061373 | Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00417898 | Study of Aspirin and TPA in Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT03824938 | Aspirin for Exercise in Multiple Sclerosis (ASPIRE) | multiple sclerosis | Aspirin (NPC311219) | NP level |
NCT01324388 | A Study of the Effect of LY2189265 on Two Blood Pressure Drugs | type 2 diabetes mellitus | Metoprolol (NPC320242) | NP level |
NCT02497820 | Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers | Lynch syndrome | Aspirin (NPC311219) | NP level |
NCT01337674 | Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010) | hypertension | Metoprolol (NPC320242) | NP level |
NCT01415505 | Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02177500 | Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02900729 | Randomized Controlled Trial of Renal Denervation for Resistant Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02034292 | Safety Study of APD-791 With Aspirin and/or Clopidogrel | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT04834557 | Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Digoxin (NPC173555) | NP level |
NCT01259817 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | essential thrombocythemia;polycythemia vera | Aspirin (NPC311219) | NP level |
NCT00695955 | One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00998075 | Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately | peptic ulcer disease | Aspirin (NPC311219) | NP level |
NCT01015729 | Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately | peptic ulcer disease | Aspirin (NPC311219) | NP level |
NCT00496834 | LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00872586 | Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00739596 | Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03186456 | Human Umbilical Cord Mesenchymal Stem Cell Therapy (19 | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT00062023 | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02813824 | Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome | Lynch syndrome | Aspirin (NPC311219) | NP level |
NCT02772601 | This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis | psoriasis | Metoprolol (NPC320242) | NP level |
NCT00931710 | Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02047539 | Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis | psychosis | Aspirin (NPC311219) | NP level |
NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT04038489 | COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
NCT02832531 | INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority | rheumatic heart disease | Aspirin (NPC311219) | NP level |
NCT02927249 | Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | breast cancer | Aspirin (NPC311219) | NP level |
NCT02293395 | A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00140959 | Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03461003 | N-of-1 Trials In Children With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01211821 | Effect of BMS-914392 on Pharmacokinetics of Metoprolol | atrial fibrillation | Metoprolol (NPC320242) | NP level |
NCT02466490 | Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04554433 | New Treatment for COVID-19 Using Ethanol Vapor Inhalation . | COVID-19 | Aspirin (NPC311219) | NP level |
NCT00244426 | S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT00185172 | Olmesartan in Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01321255 | Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT04860713 | An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache | pain | Aspirin (NPC311219) | NP level |
NCT01294462 | Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00386607 | A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02212639 | Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma | Kaposi's sarcoma | Digoxin (NPC173555) | NP level |
NCT02268565 | Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms | insomnia | Aspirin (NPC311219) | NP level |
NCT00171132 | VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02243098 | Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects | diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT02377661 | Lowering Blood Pressure in Primary Care in Vienna | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00027066 | Warfarin Versus Aspirin Recurrent Stroke Study | stroke | Aspirin (NPC311219) | NP level |
NCT02467582 | Adjuvant Aspirin Treatment for Colon Cancer Patients | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT00993421 | A Weight Loss Study in Overweight Men and Women | obesity | Metoprolol (NPC320242) | NP level |
NCT00129805 | Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT00698646 | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02493322 | Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02776540 | Clopidogrel for Acute Ischaemia of Recent Onset | stroke | Aspirin (NPC311219) | NP level |
NCT03684772 | Topical Ionic Contra-Viral Therapy in Actinic Keratosis | actinic keratosis | Digoxin (NPC173555) | NP level |
NCT00587496 | 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers | Herpes simplex infection | Aspirin (NPC311219) | NP level |
NCT00185068 | An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | HIV-1 infection | Aspirin (NPC311219) | NP level |
NCT01523002 | Drug Interaction Study of Pyronaridine-artesunate and Metoprolol and Pyronaridine-artesunate Re-dosing Study in Healthy Volunteers | malaria | Metoprolol (NPC320242) | NP level |
NCT02433587 | Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT02106845 | Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors. | neoplasm | Digoxin (NPC173555) | NP level |
NCT04962451 | Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT00357682 | A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia | esophageal cancer | Aspirin (NPC311219) | NP level |
NCT04182100 | Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply | polycythemia vera | Aspirin (NPC311219) | NP level |
NCT01720108 | Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT00178464 | Aspirin Prophylaxis in Sickle Cell Disease | sickle cell anemia | Aspirin (NPC311219) | NP level |
NCT00708344 | ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01429272 | Minocycline and Aspirin in the Treatment of Bipolar Depression | bipolar disorder | Aspirin (NPC311219) | NP level |
NCT01675115 | Efficacy of BNG-1 to Treat Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00144222 | Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00170989 | Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00795847 | Morning Hypertension and Preminent Therapy Study | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000152 | Randomized Trial of Beta-Carotene and Macular Degeneration | macular degeneration | Aspirin (NPC311219) | NP level |
NCT01748123 | EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00732927 | Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion | retinal vein occlusion | Aspirin (NPC311219) | NP level |
NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | nasopharyngeal neoplasm | Aspirin (NPC311219) | NP level |
NCT02945033 | Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT03794596 | A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
NCT03031496 | Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01790997 | Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00338936 | Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05056896 | ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT03197779 | A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT02647086 | Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD) | atopic eczema | Metoprolol (NPC320242) | NP level |
NCT00257491 | Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02456844 | Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients | rheumatoid arthritis | Digoxin (NPC173555) | NP level |
NCT00923091 | Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000556 | Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT02172586 | Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01030458 | Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01047566 | Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE) | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT01028079 | Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain | Low back pain | Aspirin (NPC311219) | NP level |
NCT00403481 | An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02596126 | Secondary Prevention of Cardiovascular Disease in the Elderly Trial | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT05357911 | A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin | neoplasm | Digoxin (NPC173555) | NP level |
NCT01436201 | A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants | type 2 diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | atherosclerosis;coronary artery disease;Hypercholesterolemia | Metoprolol (NPC320242);Hydrochlorothiazide (NPC321053) | NP level |
NCT02294539 | Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03428373 | Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT02738632 | Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01005602 | Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care | heart failure | Digoxin (NPC173555) | NP level |
NCT02249910 | Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects | diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT02007837 | Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial | preeclampsia | Aspirin (NPC311219) | NP level |
NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT02301780 | Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention | preeclampsia | Aspirin (NPC311219) | NP level |
NCT02373163 | INTERVENCION Trial | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00273299 | Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT00261586 | A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach | pain | Aspirin (NPC311219) | NP level |
NCT01288742 | TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin | hepatitis C virus infection | Digoxin (NPC173555) | NP level |
NCT00661895 | Black Education and Treatment of Hypertension (BEAT HTN) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02895113 | Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes | diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT05273775 | A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers | chronic hepatitis B virus infection | Digoxin (NPC173555) | NP level |
NCT04588727 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01526122 | Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration | atherosclerosis | Aspirin (NPC311219) | NP level |
NCT03197194 | A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion | retinal artery occlusion | Aspirin (NPC311219) | NP level |
NCT00492128 | Kanagawa Combination Anti-hypertensive Therapy (K-CAT) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00295542 | Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000525 | Diuretics, Hypertension, and Arrhythmias Clinical Trial | sudden cardiac arrest;hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | COVID-19;severe acute respiratory syndrome | Aspirin (NPC311219) | NP level |
NCT00776477 | The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease | atherosclerosis | Aspirin (NPC311219) | NP level |
NCT03152409 | Salicylic Augmentation in Depression | major depressive disorder;treatment resistant depression | Aspirin (NPC311219) | NP level |
NCT00007683 | Warfarin and Antiplatelet Therapy in Chronic Heart Failure | heart failure | Aspirin (NPC311219) | NP level |
NCT00238667 | To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection | stroke | Aspirin (NPC311219) | NP level |
NCT00202020 | Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT00002527 | Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT04526951 | TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) | retinal artery occlusion | Aspirin (NPC311219) | NP level |
NCT00814268 | COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT02071004 | DS1040b/Aspirin Drug/Drug Interaction Study | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT03093207 | Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis | periodontitis | Aspirin (NPC311219) | NP level |
NCT00135551 | Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients | cardiovascular disease | Hydrochlorothiazide (NPC321053) | NP level |
NCT02183701 | Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00688428 | Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination | gastrointestinal disease;ulcer disease | Aspirin (NPC311219) | NP level |
NCT00398541 | Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03765619 | Postoperative Aspirin and Ankle Fracture Healing | bone fracture | Aspirin (NPC311219) | NP level |
NCT02062255 | Impact of COX2 on Sera Biomarkers From Obese Subjects | breast cancer | Aspirin (NPC311219) | NP level |
NCT00574834 | Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes | metabolic syndrome | Hydrochlorothiazide (NPC321053) | NP level |
NCT00224549 | PHARES Study: Management of Resistant Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000500 | Physicians' Health Study | Myocardial Ischemia | Aspirin (NPC311219) | NP level |
NCT03176498 | MK-5348-017) | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT03246555 | Fimasartan in the Senior Subjects | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01504867 | LIPS-A: Lung Injury Prevention Study With Aspirin | acute respiratory distress syndrome | Aspirin (NPC311219) | NP level |
NCT05035316 | Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT) | bipolar disorder | Aspirin (NPC311219) | NP level |
NCT01431053 | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | breast neoplasm | Aspirin (NPC311219) | NP level |
NCT01238185 | Aspirin Mouthwash in Treating Patients With Oral Leukoplakia | Oral leukoplakia | Aspirin (NPC311219) | NP level |
NCT02521246 | Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01659307 | The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury | acute lung injury | Aspirin (NPC311219) | NP level |
NCT02544815 | Digoxin Short Term Treatment Assessment Randomized Trial in AHF | heart failure | Digoxin (NPC173555) | NP level |
NCT03578042 | Fixed-Free HTN Trial | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03051646 | Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis | Fatigue | Aspirin (NPC311219) | NP level |
NCT03396952 | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
NCT00959621 | Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion | habitual abortion | Aspirin (NPC311219) | NP level |
NCT01646814 | Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects | duodenal ulcer | Aspirin (NPC311219) | NP level |
NCT00152633 | Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension | hypertension | Metoprolol (NPC320242) | NP level |
NCT00902538 | Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00642096 | Factorial Study of Metoprolol Succinate TOPROL-XL (324A) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00872534 | Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers | gastrointestinal disease | Aspirin (NPC311219) | NP level |
NCT00175032 | A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin | osteoarthritis;Peptic ulcer | Aspirin (NPC311219) | NP level |
NCT00910065 | BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00589303 | AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study | atrial fibrillation;heart failure | Metoprolol (NPC320242) | NP level |
NCT02489786 | A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT02164578 | Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT01422109 | Comparative Pharmacokinetics of YH14659 | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT05156879 | Aspirin for the Management of Endometriosis-associated Pelvic Pain | pain | Aspirin (NPC311219) | NP level |
NCT03103152 | A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression | prostate cancer | Aspirin (NPC311219) | NP level |
NCT00915733 | Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT05035277 | AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation | aortic stenosis | Aspirin (NPC311219) | NP level |
NCT00000527 | Recurrent Carotid Stenosis | heart disease;internal carotid artery stenosis | Aspirin (NPC311219) | NP level |
NCT00368277 | A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00699998 | A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00566904 | New Topical Treatment for Continued Pain After Shingles | postherpetic neuralgia | Aspirin (NPC311219) | NP level |
NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | stroke | Aspirin (NPC311219) | NP level |
NCT02513927 | The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese | hypertension | Metoprolol (NPC320242) | NP level |
NCT00235248 | Aortic Arch Related Cerebral Hazard Trial (ARCH) | brain infarction;transient ischemic attack | Aspirin (NPC311219) | NP level |
NCT00142584 | Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension | hypertension | Metoprolol (NPC320242) | NP level |
NCT00182039 | POISE Trial: Perioperative Ischemic Evaluation Study | cardiovascular disease | Metoprolol (NPC320242) | NP level |
NCT03147092 | Matão Controlling Hypertension (MatCH Study): Rationale and Design | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00105209 | A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Aspirin (NPC311219) | NP level |
NCT02174328 | Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. | preeclampsia | Aspirin (NPC311219) | NP level |
NCT04887194 | PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates | neoplasm | Digoxin (NPC173555) | NP level |
NCT02545933 | Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT01198249 | Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01355354 | Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects | rheumatoid arthritis | Digoxin (NPC173555) | NP level |
NCT00649389 | Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00185185 | Olmesartan Medoxomil in Atherosclerosis | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03661411 | Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT02175355 | Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01302899 | To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy | kidney disease | Hydrochlorothiazide (NPC321053) | NP level |
NCT00760266 | Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03718273 | IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study). | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT03480776 | ASA in Prevention of Ovarian Cancer (STICs and STONEs) | ovarian cancer | Aspirin (NPC311219) | NP level |
NCT01012349 | Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache. | Tension-type headache | Aspirin (NPC311219) | NP level |
NCT02607072 | Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT01103245 | Aldosterone and the Metabolic Syndrome | diabetes mellitus | Hydrochlorothiazide (NPC321053) | NP level |
NCT03696758 | Improving Right Ventricular Function in Young Adults Born Preterm | premature birth | Metoprolol (NPC320242) | NP level |
NCT00887510 | Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01271374 | Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00942994 | Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00751751 | Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04952051 | Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02326350 | ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial | acute respiratory distress syndrome | Aspirin (NPC311219) | NP level |
NCT02434861 | An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects | Chemotherapy-induced nausea and vomiting | Digoxin (NPC173555) | NP level |
NCT03249285 | Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00926289 | Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02744456 | N-of-1 Trials for Blood Pressure Medications in Adults | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01739556 | On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT01922141 | Aliskiren Study of Safety and Efficacy in Senior Hypertensives | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00751829 | Isolated Systolic Hypertension in the Elderly and Very Elderly | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02072226 | A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT01704638 | Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes | depressive disorder | Digoxin (NPC173555) | NP level |
NCT02548650 | Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT00500604 | Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00055731 | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | prostate cancer | Aspirin (NPC311219) | NP level |
NCT00996281 | Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00171782 | Hypertension and Cardiovascular Risk Factors | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02138292 | A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma | melanoma | Digoxin (NPC173555) | NP level |
NCT04937088 | Outpatient Liquid Aspirin (OLA) | COVID-19 | Aspirin (NPC311219) | NP level |
NCT04142125 | Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00171054 | Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00264212 | AMISH : Aprovel for Management of Isolated Systolic Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02965703 | Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | colorectal adenoma | Aspirin (NPC311219) | NP level |
NCT01459627 | Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT03559868 | Inhibition of Sterile Inflammation by Digoxin | inflammation | Digoxin (NPC173555) | NP level |
NCT00123903 | COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria | congestive heart failure | Metoprolol (NPC320242) | NP level |
NCT00501059 | A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT00940784 | Clopidogrel and Aspirin for the Treatment of Polycythemia Vera | polycythemia vera | Aspirin (NPC311219) | NP level |
NCT01797575 | N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder | bipolar disorder | Aspirin (NPC311219) | NP level |
NCT01101009 | Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01552798 | Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache | Headache | Aspirin (NPC311219) | NP level |
NCT04754789 | Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI | ST Elevation Myocardial Infarction | Aspirin (NPC311219) | NP level |
NCT00482261 | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT01517399 | Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects | neoplasm | Digoxin (NPC173555) | NP level |
NCT00548067 | Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01042704 | Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT04066725 | Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
NCT02326779 | Low-dose Aspirin Therapy for Esophageal Cancer | esophageal cancer | Aspirin (NPC311219) | NP level |
NCT01994720 | [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] | stroke | Aspirin (NPC311219) | NP level |
NCT00651287 | A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00976495 | Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Hydrochlorothiazide (NPC321053) | NP level |
NCT00171561 | Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria. | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00846365 | Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00547300 | Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension | hypertension | Metoprolol (NPC320242) | NP level |
NCT02740712 | Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | neoplasm | Digoxin (NPC173555) | NP level |
NCT01320982 | Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder | schizoaffective disorder;schizophrenia | Aspirin (NPC311219) | NP level |
NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | prostate cancer | Aspirin (NPC311219) | NP level |
NCT00818883 | Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000499 | Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) | heart disease;hypertension | Metoprolol (NPC320242) | NP level |
NCT00223717 | Treatment of Supine Hypertension in Autonomic Failure | hypertension | Aspirin (NPC311219) | NP level |
NCT00307060 | MK0954A-264 Filter Study (0954A-264)(COMPLETED) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00327145 | A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01699776 | Efficacy Study of Digoxin & Ivabradine to Treat Heart Failure | heart failure | Digoxin (NPC173555) | NP level |
NCT02081638 | Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study | HIV infection | Aspirin (NPC311219) | NP level |
NCT01070030 | Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00434967 | Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03927313 | Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM | meningitis | Aspirin (NPC311219) | NP level |
NCT04535804 | Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery | endometriosis of uterus | Aspirin (NPC311219) | NP level |
NCT00300365 | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL | metabolic syndrome | Aspirin (NPC311219) | NP level |
NCT01768637 | Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study | chronic kidney disease | Aspirin (NPC311219) | NP level |
NCT00402103 | An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00739674 | SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00092209 | Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04778787 | Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention | congestive heart failure | Digoxin (NPC173555) | NP level |
NCT02177435 | Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01633528 | The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy | infertility | Aspirin (NPC311219) | NP level |
NCT02915666 | A Clinical Trial of Patients With Melanoma | melanoma | Digoxin (NPC173555) | NP level |
NCT00367094 | Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03113071 | Safety and Activity of Digoxin With Decitabine in Adult AML and MDS | acute myeloid leukemia;myelodysplastic syndrome | Digoxin (NPC173555) | NP level |
NCT01755520 | Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG | acute coronary syndrome;angina pectoris | Aspirin (NPC311219) | NP level |
NCT04243278 | Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC) | preeclampsia | Aspirin (NPC311219) | NP level |
NCT04809818 | A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT03459560 | Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants | cardiovascular disease | Metoprolol (NPC320242) | NP level |
NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | COVID-19 | Aspirin (NPC311219) | NP level |
NCT02227368 | Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT00644085 | Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)? | infertility | Aspirin (NPC311219) | NP level |
NCT03459560 | Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT03433833 | Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing | von Hippel-Lindau disease | Digoxin (NPC173555) | NP level |
NCT00963443 | Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold | common cold | Aspirin (NPC311219) | NP level |
NCT02427126 | Apixaban for Treatment of Embolic Stroke of Undetermined Source | stroke | Aspirin (NPC311219) | NP level |
NCT00960869 | Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | gastric ulcer | Aspirin (NPC311219) | NP level |
NCT02323516 | Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies. | cancer | Aspirin (NPC311219) | NP level |
NCT01911780 | Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02772354 | Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population | Ventricular arrhythmia | Metoprolol (NPC320242) | NP level |
NCT00326768 | Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01245608 | Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables. | cardiovascular disease | Metoprolol (NPC320242) | NP level |
NCT00000491 | Aspirin-Myocardial Infarction Study (AMIS) | Myocardial Ischemia;myocardial infarction | Aspirin (NPC311219) | NP level |
NCT00412932 | An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00765674 | Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05428072 | Alcohol, Gut Leakiness, & Liver Disease | alcoholic liver disease | Aspirin (NPC311219) | NP level |
NCT01763931 | DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer | breast cancer | Digoxin (NPC173555) | NP level |
NCT01822860 | Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00443612 | Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00821574 | Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00280540 | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00331786 | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02370680 | Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01863173 | Effect of Metoprolol on Thalassemia Cardiomyopathy | Beta-thalassemia | Metoprolol (NPC320242) | NP level |
NCT02762123 | A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates | rheumatoid arthritis | Digoxin (NPC173555) | NP level |
NCT00223717 | Treatment of Supine Hypertension in Autonomic Failure | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02797249 | Low Dose Aspirin in the Prevention of Preeclampsia in China | preeclampsia | Aspirin (NPC311219) | NP level |
NCT00250562 | A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan. | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03464305 | ASPIRIN Trial Belgium | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT03541109 | A Polypill for Secondary Prevention of Ischemic Heart Disease | ST Elevation Myocardial Infarction | Metoprolol (NPC320242);Aspirin (NPC311219) | NP level |
NCT02483936 | Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02008942 | Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT01819220 | Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01103622 | Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients | type 2 diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT01762787 | Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers | inflammation | Aspirin (NPC311219) | NP level |
NCT00896389 | Salt Loading and Thiazide Intervention Study | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04128956 | Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS | Venous thrombosis | Aspirin (NPC311219) | NP level |
NCT02072330 | Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension. | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01518231 | Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT00269438 | New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis | ulcerative colitis | Aspirin (NPC311219) | NP level |
NCT02222480 | A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00797056 | Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease | peripheral vascular disease | Aspirin (NPC311219) | NP level |
NCT00311740 | A Study of VAH631 in Patients With Essential Hypertension (Factorial Study) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00991783 | A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers | essential hypertension | Digoxin (NPC173555) | NP level |
NCT04645004 | Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy | preeclampsia | Aspirin (NPC311219) | NP level |
NCT04078568 | Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease | mucocutaneous lymph node syndrome | Aspirin (NPC311219) | NP level |
NCT00630877 | Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin | Disorder of lipid metabolism | Aspirin (NPC311219) | NP level |
NCT03946514 | Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00384865 | A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Aspirin (NPC311219) | NP level |
NCT01313702 | Single Pill to Avert Cardiovascular Events | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039 | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT03056703 | Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets | pain | Aspirin (NPC311219) | NP level |
NCT00000469 | Asymptomatic Carotid Artery Plaque Study (ACAPS) | heart disease;internal carotid artery stenosis;cerebral atherosclerosis | Aspirin (NPC311219) | NP level |
NCT01245608 | Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables. | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02742467 | Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00447603 | A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02984384 | PREVENTion of Clot in Orthopaedic Trauma | injury;thrombotic disease | Aspirin (NPC311219) | NP level |
NCT01661322 | Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT03225352 | A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets | pain | Aspirin (NPC311219) | NP level |
NCT00335452 | Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT01057537 | UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | cardiovascular disease | Metoprolol (NPC320242) | NP level |
NCT03574909 | IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes | diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT00772499 | Vascular Improvement With Olmesartan Medoxomil Study | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01692301 | Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03298802 | Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide | preeclampsia | Hydrochlorothiazide (NPC321053) | NP level |
NCT00790452 | Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma | glioblastoma multiforme | Aspirin (NPC311219) | NP level |
NCT03377543 | Sleep and Inflammatory Resolution Pathway | inflammation | Aspirin (NPC311219) | NP level |
NCT00886600 | A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02677545 | Ticagrelor Versus Clopidogrel in Carotid Artery Stenting | internal carotid artery stenosis | Aspirin (NPC311219) | NP level |
NCT00277472 | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03057431 | Randomized Double-blind Placebo-controlled Trial Assessing the Efficacy of Standard and Low Dose Hydrochlorothiazide Treatment in the Prevention of Recurrent Nephrolithiasis | nephrolithiasis | Hydrochlorothiazide (NPC321053) | NP level |
NCT05265299 | Trial to Determine Effective Aspirin Dose in COPD | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
NCT01635426 | Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages | pregnancy | Aspirin (NPC311219) | NP level |
NCT02869009 | Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00712465 | An Interaction Study With Digoxin and AZD1305 | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT01056874 | Effect Of Maraviroc On The Pharmacokinetics Of Digoxin | HIV infection | Digoxin (NPC173555) | NP level |
NCT03047837 | A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT02217501 | Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT01033526 | Symptomatic Treatment of Common Cold Symptoms | common cold | Aspirin (NPC311219) | NP level |
NCT03541109 | A Polypill for Secondary Prevention of Ischemic Heart Disease | acute myocardial infarction | Metoprolol (NPC320242) | NP level |
NCT03961334 | MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention | stroke | Aspirin (NPC311219) | NP level |
NCT00865917 | Cardiovascular Effects of Selective I(f)-Channel Blockade | orthostatic hypotension | Metoprolol (NPC320242) | NP level |
NCT00400777 | Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02269696 | The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients | breast cancer | Metoprolol (NPC320242) | NP level |
NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | essential thrombocythemia;polycythemia vera | Aspirin (NPC311219) | NP level |
NCT03971929 | Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00400218 | Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000510 | Platelet-Inhibitor Drug Trial in Coronary Angioplasty | angina pectoris;Myocardial Ischemia | Aspirin (NPC311219) | NP level |
NCT03149445 | Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) | Prader-Willi syndrome | Metoprolol (NPC320242) | NP level |
NCT01486433 | The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects | Hypertriglyceridemia | Aspirin (NPC311219) | NP level |
NCT00791258 | A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01802775 | Edoxaban in Peripheral Arterial Disease | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT00578721 | Trial of Aspirin and Arginine Restriction in Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT01831011 | Mildronate for Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00670566 | Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01046942 | ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery | thrombophilia;thrombotic disease | Aspirin (NPC311219) | NP level |
NCT04284397 | Identification of Critical Thermal Environments for Aged Adults | aging | Aspirin (NPC311219) | NP level |
NCT04860804 | A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain | pain | Aspirin (NPC311219) | NP level |
NCT00487123 | Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03219645 | Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT02798913 | Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT00797316 | Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01051778 | Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome | habitual abortion | Aspirin (NPC311219) | NP level |
NCT04557475 | Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction | fetal growth restriction | Aspirin (NPC311219) | NP level |
NCT00623779 | Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT00953680 | Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02685748 | Aspirin in Young Psychotic Patients | schizophrenia | Aspirin (NPC311219) | NP level |
NCT01276288 | Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Hydrochlorothiazide (NPC321053) | NP level |
NCT00705575 | Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05122455 | Effects of Edoxaban on Platelet Aggregation | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT04214990 | Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients | gastric cancer | Aspirin (NPC311219) | NP level |
NCT04498273 | COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 | COVID-19 | Aspirin (NPC311219) | NP level |
NCT00000151 | Early Treatment Diabetic Retinopathy Study (ETDRS) | Blindness;diabetic retinopathy | Aspirin (NPC311219) | NP level |
NCT01515657 | Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT04363840 | The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations | blood coagulation disease;Disseminated intravascular coagulation;vitamin D deficiency;COVID-19 | Aspirin (NPC311219) | NP level |
NCT02906761 | Aspirin for Uncontrolled Asthma | asthma | Aspirin (NPC311219) | NP level |
NCT00425997 | Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03131973 | Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin | rheumatoid arthritis | Digoxin (NPC173555) | NP level |
NCT01496521 | Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols | squamous cell carcinoma | Aspirin (NPC311219) | NP level |
NCT01616615 | Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation | placental insufficiency | Aspirin (NPC311219) | NP level |
NCT03487406 | Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
NCT01784159 | ASpirin for Patients With SEPsis and SeptIc Shock | Sepsis | Aspirin (NPC311219) | NP level |
NCT04070573 | Low Doses of Aspirin in the Prevention of Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
NCT05233124 | Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT02164864 | BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT00000496 | Platelet Drug Trial in Coronary Disease Progression | Myocardial Ischemia | Aspirin (NPC311219) | NP level |
NCT03899987 | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery | prostate adenocarcinoma | Aspirin (NPC311219) | NP level |
NCT02125409 | Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT04425902 | Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults | HIV infection | Digoxin (NPC173555);Metoprolol (NPC320242) | NP level |
NCT02177487 | Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00727948 | The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy | breast cancer | Aspirin (NPC311219) | NP level |
NCT00355589 | Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02419820 | Dose-escalation, Repeated and Single Oral Dosing Study | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT04504045 | Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metoprolol (NPC320242) | NP level |
NCT05373264 | HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life | Autosomal dominant polycystic kidney disease | Hydrochlorothiazide (NPC321053) | NP level |
NCT00316927 | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | prostate cancer | Aspirin (NPC311219) | NP level |
NCT02940379 | A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol | type 2 diabetes mellitus | Metoprolol (NPC320242) | NP level |
NCT03543683 | Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT00902304 | Valsartan Intensified Primary Care Reduction of Blood Pressure Study | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00171015 | VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03787927 | Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets | hemorrhage | Aspirin (NPC311219) | NP level |
NCT00697021 | Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT02929888 | Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients | acute myocardial infarction | Aspirin (NPC311219) | NP level |
NCT00240474 | A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03541109 | A Polypill for Secondary Prevention of Ischemic Heart Disease | Non-ST Elevation Myocardial Infarction | Aspirin (NPC311219);Metoprolol (NPC320242) | NP level |
NCT00220233 | Olmesartan as an add-on to Amlodipine in Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03063541 | Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms | brain aneurysm | Aspirin (NPC311219) | NP level |
NCT01657071 | Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT01890005 | Low Dose Aspirin for the Prevention of Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
NCT00813722 | Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00546754 | BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05036109 | DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease | colorectal carcinoma;malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT03136237 | A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions | hereditary angioedema | Digoxin (NPC173555) | NP level |
NCT02224131 | Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling | stroke | Aspirin (NPC311219) | NP level |
NCT04466670 | Hemostasis in COVID-19: an Adaptive Clinical Trial | COVID-19 | Aspirin (NPC311219) | NP level |
NCT04160546 | Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP) | chronic myelogenous leukemia | Aspirin (NPC311219) | NP level |
NCT02737891 | Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metoprolol (NPC320242) | NP level |
NCT01453400 | Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain | pharyngitis | Aspirin (NPC311219) | NP level |
NCT01765569 | A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma | melanoma | Digoxin (NPC173555) | NP level |
NCT00276380 | A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT04493931 | Drug-drug Interaction Study of Gepotidacin | infection | Digoxin (NPC173555) | NP level |
NCT02647099 | Adjuvant Low Dose Aspirin in Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02177422 | Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | atopic eczema | Metoprolol (NPC320242) | NP level |
NCT02671461 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT00000157 | Randomized Trial of Aspirin and Cataracts in U.S. Physicians | cataract | Aspirin (NPC311219) | NP level |
NCT03578822 | Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial | stroke | Aspirin (NPC311219) | NP level |
NCT02158806 | Low Dose Aspirin for Venous Leg Ulcers | varicose ulcer | Aspirin (NPC311219) | NP level |
NCT02521233 | Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01709994 | Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients | chronic kidney disease | Aspirin (NPC311219) | NP level |
NCT03003325 | The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV | polycythemia vera | Aspirin (NPC311219) | NP level |
NCT00670787 | Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01248468 | Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
NCT03245489 | Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Aspirin (NPC311219) | NP level |
NCT00871871 | Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01800357 | Efficacy and Safety of Mildronate for Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT02341638 | Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT01519635 | Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03889795 | Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors | pancreatic carcinoma | Digoxin (NPC173555) | NP level |
NCT02960126 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT00232882 | Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02237365 | A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis | meningitis | Aspirin (NPC311219) | NP level |
NCT02271399 | Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT04535518 | Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease | mucocutaneous lymph node syndrome | Aspirin (NPC311219) | NP level |
NCT01887288 | Capecitabine With Digoxin for Metastatic Breast Cancer | breast cancer | Digoxin (NPC173555) | NP level |
NCT00667719 | A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00153049 | 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00621153 | Candesartan Effect in Second Stage Arterial Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02155985 | Modulation of Immune Activation by Aspirin | HIV-1 infection | Aspirin (NPC311219) | NP level |
NCT00425074 | Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism. | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01733485 | Electrophilic Fatty Acid Derivatives in Asthma | asthma | Aspirin (NPC311219) | NP level |
NCT00360178 | Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00671424 | A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide | type 2 diabetes mellitus | Hydrochlorothiazide (NPC321053) | NP level |
NCT04381936 | Randomised Evaluation of COVID-19 Therapy | severe acute respiratory syndrome | Aspirin (NPC311219) | NP level |
NCT03667326 | Postpartum Low-Dose Aspirin and Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
NCT01211925 | Distal Venous Arterialisation of Ischemic Limb | ischemia | Aspirin (NPC311219) | NP level |
NCT00311402 | JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme | stroke | Aspirin (NPC311219) | NP level |
NCT00267943 | Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00648895 | A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients | hypertension | Metoprolol (NPC320242) | NP level |
NCT00961350 | A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | gastric ulcer | Aspirin (NPC311219) | NP level |
NCT00607035 | The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00390546 | Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia | Supraventricular tachycardia | Digoxin (NPC173555) | NP level |
NCT04216693 | Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH) | non-alcoholic steatohepatitis | Digoxin (NPC173555) | NP level |
NCT00170950 | Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03197324 | Bexagliflozin Drug/Drug Interaction Study With Digoxin | diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT01583036 | An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed | epilepsy | Digoxin (NPC173555) | NP level |
NCT01741922 | Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients | hypertension | Aspirin (NPC311219) | NP level |
NCT04145258 | Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | meningitis | Aspirin (NPC311219) | NP level |
NCT02521285 | Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation | Barrett's esophagus | Aspirin (NPC311219) | NP level |
NCT04240834 | Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT04229264 | Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. | ischemia | Aspirin (NPC311219) | NP level |
NCT00426478 | Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01103440 | Aspirin Resistance and Percutaneous Coronary Intervention (PCI) | angina pectoris | Aspirin (NPC311219) | NP level |
NCT04824911 | Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease | stroke | Aspirin (NPC311219) | NP level |
NCT04927299 | Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00168779 | Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03276598 | A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00246519 | Pharmacogenomic Evaluation of Antihypertensive Responses | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00004727 | Antiplatelet Therapy to Prevent Stroke in African Americans | stroke | Aspirin (NPC311219) | NP level |
NCT01058902 | The Effect Of Aspirin On Survival in Lung Cancer | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT02834403 | L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients | breast cancer | Aspirin (NPC311219) | NP level |
NCT00004728 | Aspirin Or Warfarin To Prevent Stroke | atherosclerosis;cerebral infarction;stroke | Aspirin (NPC311219) | NP level |
NCT01082874 | PeriOperative ISchemic Evaluation-2 Trial | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT00430638 | A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01370655 | A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02217852 | Treatment of Hypertension in Tibetan Adult Population | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05308030 | Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT04410328 | Aggrenox To Treat Acute Covid-19 | COVID-19 | Aspirin (NPC311219) | NP level |
NCT02659384 | Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer | ovarian neoplasm | Aspirin (NPC311219) | NP level |
NCT02770274 | Cilostazol Following Peripheral Endovascular Procedures | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT03378297 | IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC | ovarian cancer | Aspirin (NPC311219) | NP level |
NCT00374855 | A Study in People With Mild Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05073718 | SARS-CoV-2 and Acetylsalicylic Acid (SARA) | COVID-19 | Aspirin (NPC311219) | NP level |
NCT02285738 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | cancer | Aspirin (NPC311219) | NP level |
NCT01629329 | Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
NCT01033071 | Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension. | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00430508 | Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02596126 | Secondary Prevention of Cardiovascular Disease in the Elderly Trial | myocardial infarction | Metoprolol (NPC320242) | NP level |
NCT01328145 | Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
NCT00486512 | Chemoprevention of Colorectal Adenomas | Familial adenomatous polyposis | Aspirin (NPC311219) | NP level |
NCT03387657 | A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide | type 2 diabetes mellitus | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000479 | Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer | cerebrovascular disorder;Myocardial Ischemia;myocardial infarction | Aspirin (NPC311219) | NP level |
NCT02183688 | Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients | migraine disorder | Aspirin (NPC311219) | NP level |
NCT02775240 | Study of SHP620 (Maribavir) in Healthy Adults | cytomegalovirus infection | Digoxin (NPC173555) | NP level |
NCT03170115 | Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer | rectum cancer | Aspirin (NPC311219) | NP level |
NCT00054938 | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | systemic lupus erythematosus | Aspirin (NPC311219) | NP level |
NCT02602938 | Aspirin on CTCs of Advanced Breast and Colorectal Cancer | neoplasm | Aspirin (NPC311219) | NP level |
NCT02989558 | A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI | aortic stenosis | Aspirin (NPC311219) | NP level |
NCT02172742 | The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin | epilepsy | Digoxin (NPC173555) | NP level |
NCT00562588 | EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA | stroke | Aspirin (NPC311219) | NP level |
NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | cataract;macular degeneration | Aspirin (NPC311219) | NP level |
NCT00935506 | Ex Vivo Human Thrombosis Chamber Study | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01162135 | Digoxin for Recurrent Prostate Cancer | prostate cancer | Digoxin (NPC173555) | NP level |
NCT02333123 | Aspirin for Venous Ulcers: Randomised Trial (AVURT) | varicose ulcer | Aspirin (NPC311219) | NP level |
NCT02391337 | Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT01973205 | Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
NCT00405613 | Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population | hemorrhage | Aspirin (NPC311219) | NP level |
NCT01012479 | Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | Gastrointestinal hemorrhage | Aspirin (NPC311219) | NP level |
NCT02185417 | Diuretic Comparison Project | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00923533 | A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00904176 | Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects | type 2 diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT01147718 | A Drug Interaction Study of Albiglutide and Digoxin | type 2 diabetes mellitus | Digoxin (NPC173555) | NP level |
NCT00430950 | Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | respiratory failure;viral pneumonia;COVID-19;venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT00783614 | Aspirin and Antiretroviral Therapy in HIV Infected Patients | HIV infection | Aspirin (NPC311219) | NP level |
NCT02046044 | Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction | heart failure | Digoxin (NPC173555) | NP level |
NCT00241007 | A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00041938 | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial | myocardial infarction;stroke | Aspirin (NPC311219) | NP level |
NCT00690521 | A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients | congestive heart failure | Hydrochlorothiazide (NPC321053) | NP level |
NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | hypertension | Metoprolol (NPC320242) | NP level |
NCT01827878 | Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions | Fish-eye disease | Hydrochlorothiazide (NPC321053) | NP level |
NCT05287191 | MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fribrillation in Critical Care | atrial fibrillation | Digoxin (NPC173555) | NP level |
NCT01707823 | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer | lung adenocarcinoma | Aspirin (NPC311219) | NP level |
NCT01975246 | Add-on to Micamlo BP Trial | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01057537 | UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02420652 | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | prostate carcinoma | Aspirin (NPC311219) | NP level |
NCT00095550 | Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02674958 | Mobilization of Endothelial Progenitor Cells and Aspirin | hypertrophic cardiomyopathy | Aspirin (NPC311219) | NP level |
NCT00731302 | Aspirin Resistance in Systemic Lupus Erythematosus (SLE) | systemic lupus erythematosus | Aspirin (NPC311219) | NP level |
NCT00274638 | PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02183220 | Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache | migraine disorder | Aspirin (NPC311219) | NP level |
NCT02313909 | Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) | stroke | Aspirin (NPC311219) | NP level |
NCT00631111 | Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain | pain | Aspirin (NPC311219) | NP level |
NCT04423627 | Sympathetic Regulation of Large Artery Stiffness in Humans With ISH | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01271985 | Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02797145 | Intensive Versus Conventional Digoxin Use in Patients With Heart Failure | heart failure | Digoxin (NPC173555) | NP level |
NCT02301286 | A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT00396656 | Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03541109 | A Polypill for Secondary Prevention of Ischemic Heart Disease | acute myocardial infarction | Aspirin (NPC311219) | NP level |
NCT03093246 | Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis | periodontitis | Aspirin (NPC311219) | NP level |
NCT00327587 | 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT01271985 | Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill | cardiovascular disease | Metoprolol (NPC320242) | NP level |
NCT00405756 | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT03783429 | Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands | heart failure | Digoxin (NPC173555) | NP level |
NCT04322552 | A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects | neoplasm | Digoxin (NPC173555) | NP level |
NCT02439190 | CV004-007 Thrombosis Chamber Study | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT04575519 | Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis | tuberculosis | Aspirin (NPC311219) | NP level |
NCT00281021 | Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Digoxin (NPC173555) | NP level |
NCT04343001 | Coronavirus Response - Active Support for Hospitalised Covid-19 Patients | COVID-19 | Aspirin (NPC311219) | NP level |
NCT01256411 | A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02277691 | A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00146341 | Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00383929 | Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00439738 | Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00684515 | Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005 | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT02120092 | The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT01266590 | A Study of LY2216684 and Digoxin in Healthy Subjects | major depressive disorder | Digoxin (NPC173555) | NP level |
NCT04094519 | A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer | prostate cancer | Digoxin (NPC173555) | NP level |
NCT00386139 | A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04972396 | ALT-801 DDI Study in Healthy Volunteers | non-alcoholic steatohepatitis | Digoxin (NPC173555) | NP level |
NCT02666742 | DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation | stroke | Aspirin (NPC311219) | NP level |
NCT03532698 | Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT00265408 | Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT02689037 | Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis | cerebral atherosclerosis | Aspirin (NPC311219) | NP level |
NCT01180205 | Telmisartan, Amlodipine and Flow Mediated Dilation | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00239369 | Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5 | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03162120 | Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation | atrial fibrillation | Metoprolol (NPC320242) | NP level |
NCT00496769 | A Phase III Study of Apixaban in Patients With Atrial Fibrillation | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT01796951 | Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers | nicotine dependence | Aspirin (NPC311219) | NP level |
NCT02260622 | Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia | ischemia | Aspirin (NPC311219) | NP level |
NCT04153760 | Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT00653172 | Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia | pneumonia | Aspirin (NPC311219) | NP level |
NCT04379999 | Atorvastatin ± Aspirin in Lynch Syndrome Syndrome | Lynch syndrome | Aspirin (NPC311219) | NP level |
NCT03928210 | Digoxin Induced Dissolution of CTC Clusters | breast cancer | Digoxin (NPC173555) | NP level |
NCT01936233 | Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery | hepatocellular carcinoma | Aspirin (NPC311219) | NP level |
NCT00650910 | Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer | breast neoplasm | Digoxin (NPC173555) | NP level |
NCT02888327 | A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872 | influenza | Digoxin (NPC173555) | NP level |
NCT00626392 | Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia | Disorder of lipid metabolism | Aspirin (NPC311219) | NP level |
NCT04295486 | Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT00772577 | Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00133185 | A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02626234 | A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors | neoplasm | Digoxin (NPC173555) | NP level |
NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | type 2 diabetes mellitus | Hydrochlorothiazide (NPC321053);Metoprolol (NPC320242) | NP level |
NCT00441350 | Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00131846 | Diuretics In the Management of Essential Hypertension (DIME) Study | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT05491200 | Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT01362218 | Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol | Hypercholesterolemia | Aspirin (NPC311219) | NP level |
NCT01355705 | Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT00833833 | MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT03192059 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | cervical cancer;endometrial cancer | Aspirin (NPC311219) | NP level |
NCT01585623 | Drug Interaction Study of SAR302503 in Patients With Solid Tumor | neoplasm | Metoprolol (NPC320242) | NP level |
NCT01313702 | Single Pill to Avert Cardiovascular Events | cardiovascular disease | Hydrochlorothiazide (NPC321053) | NP level |
NCT02846532 | Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT00847834 | Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT02348203 | Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers | nicotine dependence | Aspirin (NPC311219) | NP level |
NCT02710071 | Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00263003 | Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00139698 | Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension | essential hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03405974 | Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip | osteonecrosis | Aspirin (NPC311219) | NP level |
NCT03179163 | Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00354991 | Hyzaar Asia HEAALTH (0954A-950) | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT04330872 | An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke. | stroke | Aspirin (NPC311219) | NP level |
NCT04188119 | A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
NCT00504413 | Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone | drug dependence | Digoxin (NPC173555) | NP level |
NCT00387517 | Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00263211 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | breast neoplasm | Aspirin (NPC311219) | NP level |
NCT00673790 | The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT00765947 | Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03341117 | Acetylsalicylic Acid and Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT02578706 | Targeting Platelets in Chronic HIV Infection | HIV-1 infection | Aspirin (NPC311219) | NP level |
NCT02675205 | Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm | brain aneurysm | Aspirin (NPC311219) | NP level |
NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19;influenza;pneumonia | Aspirin (NPC311219) | NP level |
NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | breast cancer | Aspirin (NPC311219) | NP level |
NCT02100462 | Chlorthalidone and HCTZ Impacts on Platelet Activation | hypertension | Hydrochlorothiazide (NPC321053) | NP level |
NCT03820466 | Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin | acute chest syndrome | Aspirin (NPC311219) | NP level |
NCT04062032 | Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
NCT04402385 | Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE) | preeclampsia | Aspirin (NPC311219) | NP level |
NCT00059306 | Secondary Prevention of Small Subcortical Strokes Trial | stroke | Aspirin (NPC311219) | NP level |
NCT00775762 | Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events | vascular disease | Aspirin (NPC311219) | NP level |
NCT02966119 | REstart or STop Antithrombotic Randomised Trial in France | hemorrhage | Aspirin (NPC311219) | NP level |
NCT02906800 | Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients | head and neck malignant neoplasia | Digoxin (NPC173555) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT01517399,NCT01585623,NCT04887194,NCT05357911,NCT04322552,NCT02106845,NCT02740712,NCT02626234,NCT02602938
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
FUT7,PAX8,LMNA,POLB,NAPRT,NPC1,CA2,PTGS1,BLM
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
CA1,CA2,PTGS1
NCT04834557,NCT02762123,NCT03131973,NCT01355354,NCT02456844 |
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
PTGS1
NCT03225352,NCT05156879,NCT04860804,NCT04860713,NCT00261586,NCT00631111,NCT03056703 |
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT02770274,NCT05308030,NCT02227368,NCT01802775,NCT02798913,NCT02217501,NCT00797056,NCT02433587
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
NOX4,FUT7,CA2,PTGS1,ACE,BLM,ATP1A1,ADRB1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NOX4,FUT7,RAB9A,AGTR2,PTGS1,BLM,ATP1A1,THRB
|
NADisease Category: NADisease ICD-11 Code: NA |
NOX4
NCT03559868,NCT02813824,NCT04379999,NCT03377543,NCT01762787,NCT02497820 |
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT03197779,NCT02341638,NCT02671461,NCT02846532,NCT02439190,NCT02984384,NCT01046942
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT00258245,NCT00833833,NCT01042704,NCT03428373,NCT00482261,NCT00405756,NCT01355705
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
FUT7,LMNA,PAX8,NPC1,TDP1,PTGS1,AGTR1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
RAB9A,LMNA,TSHR,CA2,PTGS1,ACE,BLM
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
POLB,ATP1A1,TP53,CA2,CA1,PTGS1
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT01162135,NCT03103152,NCT03819101,NCT04094519,NCT00055731,NCT00316927
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NCT02895113,NCT02249910,NCT03574909,NCT03197324,NCT02243098,NCT01103245
|
Cerebral ischaemic stroke, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11.5Z |
NCT03176498,NCT00004728,NCT03186456,NCT00129805,NCT00202020,NCT00684515
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
KDM4E,ADRB1,CA2,CA1,FXYD2,THRB
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
ADRB1,ADRB2
NCT02138292,NCT01765569,NCT02915666 |
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
ATP1A1,ADRB2
NCT01328145,NCT03487406,NCT05265299 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
ACE,ADRB1,ADRB2
NCT01733485,NCT02906761 |
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
ADRB1
NCT00000620,NCT00004728,NCT00776477,NCT01526122 |
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT02677545,NCT00000527,NCT02689037,NCT00000469,NCT00000469
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT02301286,NCT05036109,NCT02467582,NCT03047837,NCT03464305
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000479,NCT00000500,NCT00000510,NCT00000491,NCT00000496
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT03543683,NCT01058902,NCT00281021,NCT02387086,NCT03532698
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT01056874,NCT04425902,NCT03316534,NCT00783614,NCT02081638
|
Polycythaemia veraDisease Category: X.Extension CodesDisease ICD-11 Code: XH0453 |
NCT04182100,NCT01259817,NCT01259856,NCT00940784,NCT03003325
|
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT01973205,NCT01248468,NCT01629329,NCT02183688,NCT02183220
|
Venous thromboembolismDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD72 |
NCT01720108,NCT02271399,NCT04153760,NCT04368377,NCT04295486
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
NOX4,FUT7,TSHR,BLM,FXYD2
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
NOX4,FXYD2,BLM,PAX8,ATP1A1
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
NOX4,FUT7,AGTR1,ADRB1,FXYD2
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
NOX4,PTGS1,BLM,ADRB2,FXYD2
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
ADRB2,CA1,CA2,ADRB1
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NOX4,BLM,CA1,FXYD2
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
NPC1,CA2,ADRB2,ADRB1
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
TP53
NCT03245489,NCT02906800 |
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
NCT00357682,NCT02326779 |
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
PTGS1,CA1,CA2
|
Supraventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81 |
ATP1A1,ADRB1,ADRB2
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
THRB
NCT00626392,NCT00630877 |
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
CA1,CA2
NCT01646814 |
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
ADRB1,ADRB2
NCT00993421 |
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
PTGS1
NCT02647086,NCT03556592 |
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
AGTR1
NCT00574834,NCT00300365 |
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TP53
NCT03480776,NCT03378297 |
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT04066725,NCT04062032,NCT03396952
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01426438,NCT02578706,NCT02155985
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
NCT01755520,NCT00000510,NCT01103440
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT01302899,NCT01768637,NCT01709994
|
Acute myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41 |
NCT03541109,NCT02929888,NCT01523054
|
Other specified infectious meningitis not elsewhere classifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.Y |
NCT03927313,NCT04145258,NCT02237365
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT00405613,NCT02966119,NCT03787927
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
NCT02260622,NCT01211925,NCT04229264
|
Peptic ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61 |
NCT01015729,NCT00175032,NCT00998075
|
Congestive heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10 |
NCT04778787,NCT00123903,NCT00690521
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT00263211,NCT00650910,NCT01431053
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT00000469,NCT00000527,NCT00000499
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT05035316,NCT01797575,NCT01429272
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
FUT7,TSHR,CA1
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
RAB9A,CA2,LMNA
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
PAX8,BLM,CA2
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
PAX8,CA2,BLM
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
NOX4,FUT7,BLM
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
NCT02776540,NCT03192215,NCT02239120,NCT04330872,NCT02313909,NCT01518231,NCT00004728,NCT03578822,NCT00027066,NCT02427126,NCT00059306,NCT00276380,NCT04824911,NCT00814268,NCT02224131,NCT01994720,NCT00311402,NCT00562588,NCT03661411,NCT01661322,NCT00004727,NCT02666742,NCT04962451,NCT00238667,NCT02072226,NCT03961334,NCT00041938
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
AGTR1,ADRB1,CA2
NCT00220233,NCT00872586,NCT00996281,NCT00185185,NCT00667719,NCT00923091,NCT00430950,NCT00430508,NCT00902538,NCT01198249,NCT00991783,NCT00923533,NCT02738632,NCT00846365,NCT02277691,NCT00751751,NCT01033071,NCT01256411,NCT00185172,NCT00139698,NCT00818883 |
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
TP53
NCT03113071 |
Ventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC71 |
ADRB1
NCT02772354 |
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
PTGS1,ADRB1
|
Conduction disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC63 |
ADRB1,ADRB2
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
TP53
NCT03192059 |
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
PTGS1
NOX4 |
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CA2
NCT02268565 |
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
AGTR2,PTGS1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
THRB,TSHR
|
Cardiac arrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC9Z |
ADRB1,ATP1A1
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TP53,ATP1A1
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
PTGS1
NCT00175032 |
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
TP53
NCT03192059 |
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
ADRB2,TP53
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
ATP1A1
NCT01523002 |
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PTGS1,THRB
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
PTGS1
NCT04575519 |
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
ACE
NCT04128956 |
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
ADRB1
NCT01784159 |
Secondary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA04 |
AGTR2,AGTR1
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
PTGS1
NCT00269438 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
TP53
NCT03113071 |
Tension-type headacheDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A81 |
NCT01552798,NCT01012349
|
Common cold disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SA60 |
NCT01033526,NCT00963443
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT03152409,NCT01266590
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
NCT04972396,NCT04216693
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT04493931,NCT00587496
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT02348203,NCT01796951
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT00000152,NCT00000161
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT03541109,NCT04754789
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
CA1
NCT04214990 |
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT00653172,NCT02735707
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
NCT00000157,NCT00000161
|
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT01583036,NCT02172742
|
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT03093207,NCT03093246
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
NCT01259856,NCT01259817
|
Retinal artery occlusionsDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74.0 |
NCT03197194,NCT04526951
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
NCT00054938,NCT00731302
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
NCT02735707,NCT02888327
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT00000525,NCT00401882
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT02285738,NCT02323516
|
Cerebral aneurysm, nonrupturedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22.5 |
NCT03063541,NCT02675205
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00872534,NCT00688428
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT01320982,NCT02685748
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4
NCT03899987 |
Recurrent pregnancy lossDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA33 |
NCT01051778,NCT00959621
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04381936,NCT04324463
|
Aortic valve stenosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB70 |
NCT05035277,NCT02989558
|
HypercholesterolaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.0 |
NCT00000620,NCT01362218
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT01633528,NCT00644085
|
Gastric ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA60 |
NCT00960869,NCT00961350
|
Venous leg ulcer, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD74.3Z |
NCT02333123,NCT02158806
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
NCT02326350,NCT01504867
|
Mucocutaneous lymph node syndromeDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44.5 |
NCT04535518,NCT04078568
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
NOX4,BLM
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TSHR,BLM
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4,FUT7
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NOX4,BLM
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
TSHR,BLM
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
HSD17B10,FUT7
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
FUT7,BLM
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PTGS1
NCT03387657,NCT00000620,NCT01276288,NCT02164578,NCT00671424,NCT00976495,NCT01103622,NCT02008942,NCT01515657,NCT02737891,NCT01147718,NCT02940379,NCT05105919,NCT04504045,NCT00904176,NCT01436201,NCT01324388,NCT03341117 |
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
ATP1A1,ADRB2,ACE,AGTR1,ADRB1,AGTR2
NCT02183701,NCT03249285,NCT00171054,NCT00327145,NCT03246555,NCT00171561,NCT01337674,NCT01370655,NCT02177500,NCT00171132,NCT02185417,NCT00105209,NCT02177435,NCT00326768,NCT02217852,NCT00170950,NCT02177487,NCT00383929,NCT03461003,NCT00168779,NCT03578042,NCT00648895,NCT00000499,NCT00760266,NCT00171015,NCT03276598,NCT00384865,NCT00360178,NCT00338936,NCT00425997,NCT03946514,NCT00000620,NCT00170989,NCT01302691,NCT04927299,NCT03971929,NCT00386607,NCT00327587,NCT00146341,NCT00739596,NCT00374855,NCT00547300,NCT00223717,NCT00765674,NCT00765947,NCT00232882,NCT00739674,NCT01975246,NCT00280540,NCT00751829,NCT00386139,NCT00240448,NCT04423627,NCT00367094,NCT00698646,NCT01922141,NCT00355589,NCT01819220,NCT00307060,NCT00295542,NCT00246519,NCT02513927,NCT00368277,NCT02072330,NCT02483936,NCT01271374,NCT01180205,NCT00942994,NCT00250562,NCT01519635,NCT00902304,NCT00896389,NCT00239369,NCT00651287,NCT01741922,NCT00931710,NCT01415505,NCT00354991,NCT00439738,NCT01748123,NCT00092209,NCT02222480,NCT00396656,NCT00926289,NCT00142584,NCT00797316,NCT00953680,NCT01911780,NCT02521233,NCT00426478,NCT00430638,NCT00847834,NCT02294539,NCT00492128,NCT00224549,NCT00241007,NCT00144222,NCT02710071,NCT00000525,NCT01692301,NCT00311740,NCT04952051,NCT02493322,NCT00821574,NCT01101009,NCT00705575,NCT00152633,NCT01070030,NCT02373163,NCT02177422,NCT00621153,NCT00153049,NCT01030458,NCT03179163,NCT01012479,NCT02466490,NCT00649389,NCT00813722,NCT00795847,NCT00487123,NCT01822860,NCT00434967,NCT00670787,NCT00257491,NCT00387517,NCT00500604,NCT00496834,NCT00240474,NCT00661895,NCT03147092,NCT00887510,NCT00642096,NCT00673790,NCT00398541,NCT00695955,NCT02377661,NCT00886600,NCT00447603,NCT03031496,NCT00670566,NCT00412932,NCT00131846,NCT02175355,NCT00441350,NCT00185068,NCT02744456,NCT00095550,NCT00871871,NCT00140959,NCT00267943,NCT00708344,NCT02172586,NCT02100462,NCT00403481,NCT00772499,NCT00133185,NCT00772577,NCT00400218,NCT02742467,NCT00523744,NCT02900729,NCT00171782,NCT00607035,NCT00274638,NCT00277472,NCT00546754,NCT02521246,NCT00263003,NCT00548067,NCT00400777,NCT00402103,NCT00443612,NCT00791258,NCT00264212,NCT00273299 |
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT03162120,NCT03718273,NCT02391337,NCT00589303,NCT02960126,NCT00496769,NCT01211821,NCT00313157,NCT00244426,NCT01047566,NCT02164864,NCT00712465,NCT00623779,NCT00000556,NCT05287191,NCT02489786,NCT01830543
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PTGS1,ACE
NCT03459560,NCT04588727,NCT04792723,NCT01271985,NCT00425074,NCT00182039,NCT01082874,NCT00501059,NCT00135551,NCT01057537,NCT00935506,NCT01245608,NCT01313702,NCT02370680 |
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
PTGS1,AGTR1
NCT01739556,NCT00041938,NCT01459627,NCT05491200,NCT02596126,NCT02545933,NCT05122455,NCT01321255,NCT00915733,NCT00000479,NCT00000491,NCT00697021,NCT02548650 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
ADRB2,CA1,CA2
NCT01887288,NCT02062255,NCT04038489,NCT04188119,NCT01763931,NCT03794596,NCT00727948,NCT03491410,NCT02927249,NCT02834403,NCT03928210,NCT02269696 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
PTGS1,TP53
NCT02647099,NCT02607072,NCT00565708,NCT00578721,NCT02945033,NCT05036109,NCT02965703,NCT00331786,NCT03957902,NCT00062023,NCT00002527,NCT02125409,NCT05056896 |
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
CA2,AGTR1,ADRB1,ACE,ATP1A1
NCT00007683,NCT01005602,NCT00589303,NCT01699776,NCT03783429,NCT02046044,NCT02797145,NCT02544815 |
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT02120092,NCT01657071,NCT02034292,NCT01294462,NCT02419820,NCT00699998,NCT01755520,NCT04240834,NCT00910065,NCT01422109,NCT05233124,NCT00335452,NCT02293395
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
NCT00417898,NCT02869009,NCT00265408,NCT01675115,NCT00061373,NCT02071004,NCT04809818,NCT04142125,NCT01831011,NCT03219645,NCT01800357,NCT01790997
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT02735707,NCT04368377,NCT04498273,NCT04410328,NCT05073718,NCT04937088,NCT04466670,NCT04343001,NCT04363840,NCT04554433,NCT04324463,NCT04365309
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA1
NCT04645004,NCT04070573,NCT01890005,NCT04243278,NCT02797249,NCT04402385,NCT02301780,NCT03298802,NCT03667326,NCT02007837,NCT02174328 |
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
HSD17B10,NOX4,TP53,PAX8,LMNA,TDP1,TSHR,POLA1,ACE,BLM,FXYD2,THRB
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
HSD17B10,FUT7,TP53,PAX8,POLB,ADRB1,CA2,TDP1,TSHR,PTGS1,ATP1A1
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
NOX4,FUT7,TP53,TDP1,CA2,TSHR,ACE,ATP1A1,ADRB1,THRB
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
NOX4,TP53,PAX8,LMNA,PTGS1,POLA1,ACE,BLM,ATP1A1,FXYD2
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
TP53
|
HypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA20-BA21 |
ACE
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA2
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
PTGS1
|
Inflammatory spondyloarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA92 |
PTGS1
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
TP53
|
Functional bladder disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50 |
ADRB2
|
Reactive arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA11 |
PTGS1
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
PTGS1
|
Urinary system clinical symptonDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF8Y |
AGTR1
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
CA2
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
TP53
|
Ataxic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A03 |
PTGS1
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
ADRB2
|
Sleep-related breathing disorderDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A4Z |
ADRB2
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
PTGS1
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
PTGS1
|
Urinary system diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC2Z |
PTGS1
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
PTGS1
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
PTGS1
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
PTGS1
|
Central and peripheral nervous diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8E7Z |
ADRB1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
PTGS1
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
PTGS1
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
ADRB1
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RAB9A
|
Corneal diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A76-9A78 |
ATP1A1
|
ZosterDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E91 |
AGTR2
|
Dental diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA08 |
ATP1A1
|
Joint painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME82 |
PTGS1
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
PTGS1
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TP53
|
Circulatory system diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
ADRB1
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
ADRB1
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
ADRB1
|
CachexiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG20 |
ADRB2
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
PTGS1
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
PTGS1
|
Inherited coagulation factor deficiencyDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B14 |
PTGS1
|
Dermal/subcutaneous connective tissue atrophy/degenerationDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EE40 |
ADRB2
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TP53
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
TP53
|
HyperhidrosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EE00 |
ATP1A1
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Preterm labour/deliveryDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB00 |
ADRB2
|
Eye anterior segment structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA11 |
PTGS1
|
Injury of lung, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NB32.3Z |
NCT01659307
|
Ventricular tachycardiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC71.0 |
NCT00401882
|
Transient ischaemic attackDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10 |
NCT00235248
|
Chronic hepatitis B, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.0Z |
NCT05273775
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01496521
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT03290820
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT04284397
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT02047539
|
Blood-forming organ diseaseDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT04363840
|
Other chest painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD30.1 |
NCT03820466
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT00178464
|
Columnar metaplastic epithelium of the oesophagus, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA23.Z |
NCT02521285
|
Actinic keratosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH36H6 |
NCT03684772
|
CholelithiasisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC11 |
NCT03057431
|
Acute non-ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.1 |
NCT03541109
|
Disseminated intravascular coagulationDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B20 |
NCT04363840
|
HypoalphalipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C81.0 |
NCT01827878
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
NCT00865917
|
Retinal vascular occlusionDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74 |
NCT00732927
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
NCT03433833
|
Preterm newborn, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA21.4Z |
NCT03696758
|
HypertriglyceridaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.1 |
NCT01486433
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT01707823
|
Hereditary angioedemaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A00.14 |
NCT03136237
|
NasopharyngitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA00 |
NCT01453400
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT00486512
|
Late effects of cerebral ischemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B25.0 |
NCT00235248
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT01936233
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00000620
|
Hypertrophic cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.1 |
NCT02674958
|
FatigueDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG22 |
NCT03051646
|
ulcer diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61-DA63.Y |
NCT00688428
|
Intrauterine growth restriction, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA20.1Z |
NCT04557475
|
BlindnessDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9D90.6 |
NCT00000151
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT03170115
|
ThrombophiliaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B61 |
NCT01046942
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT03889795
|
Malignant neoplasms of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT02659384
|
Autosomal dominant polycystic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB81 |
NCT05373264
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NCT00000151
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
NCT02772601
|
Alcoholic liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94 |
NCT05428072
|
Supraventricular tachyarrhythmia, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.Z |
NCT00390546
|
Prader-Willi syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD90.3 |
NCT03149445
|
Maternal care for fetal growth restrictionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA86.4 |
NCT01616615
|
Beta thalassaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A50.2 |
NCT01863173
|
Cerebrovascular diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22-8B2Z |
NCT00000479
|
Ventricular fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC71.1 |
NCT00401882
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT01320982
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT02420652
|
Chronic rheumatic heart diseases, not elsewhere classifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC20 |
NCT02832531
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
NCT02434861
|
Viral pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.1 |
NCT04368377
|
Diseases of the circulatory system, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
NCT00775762
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
NCT02212639
|
Congenital cytomegalovirus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.3 |
NCT02775240
|
Gastrointestinal bleeding, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME24.9Z |
NCT00557921
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT01635426
|
Vitamin D deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B57 |
NCT04363840
|
Postherpetic polyneuropathyDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E91.5 |
NCT00566904
|
Fracture of unspecified body regionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56.2 |
NCT03765619
|
Chronic myeloid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4XG8 |
NCT04160546
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01288742
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT01704638
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
NCT02984384
|
OsteonecrosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB81 |
NCT03405974
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT00790452
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
NCT03152409
|
Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4G.2Z |
NCT00504413
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT01028079
|
Respiratory failureDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB41 |
NCT04368377
|
LeukoplakiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.00 |
NCT01238185
|
AdenomyosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA11 |
NCT04535804
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NCT03824938
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
NOX4
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
NOX4
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
AGTR2
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NOX4
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
NOX4
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
FUT7
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
CA1
|